License: Creative Commons Attribution 4.0 PDF - Published Version (11MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-550644
- DOI to cite this document:
- 10.5283/epub.55064
Abstract
Acute graft-versus-host disease (GvHD) remains the biggest clinical challenge and prognosis-determining complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Donor T cells are acceptedly key mediators of alloreactivity against host tissues and here especially the gut. In support of previous studies, we found that the intestinal intra-epithelial lymphocyte (IEL) ...
Owner only: item control page